Skip to Content

Nunzia Pharmaceutical Corp NUNZ Stock Quote

| Rating as of

PINX: NUNZ

Market Closed

| Currency in USD

  • Last Close < 0.01
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  0.65
  • Market Cap 1.3035 Mil
  • Volume / Avg 25,021.0 /  18,198.1
  • Price / Sales
  • Price / Book
  • Forward Div Yield 2.00%
  • Trailing Div Yield

Morningstar‘s Stock Analysis NUNZ

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics NUNZ

Company Profile NUNZ

Business Description

Nunzia Pharmaceutical Corp is a pharmaceutical and nutraceutical company. The company is involved in the autism treatment industry and the treatment of diseases such as fragile X, ADHD, and PTSD. The firm's products are segregated into adult products, kids' products, and teen products.

Contact
1627 West 14th Street
Long Beach, CA, 90813
Industry Drug Manufacturers - Specialty & Generic
Employees

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Nunzia Pharmaceutical Corp

PINX: NUNZ

Supernus Pharmaceuticals Inc

XNAS: SUPN

Rafarma Pharmaceuticals Inc

PINX: RAFA

Albireo Pharma Inc

XNAS: ALBO
Price
0.0028.170.18
Currency
USDUSDUSD
Change
$0.00 (0.00%) +$0.54 (1.95%) $0.00 (2.64%)
Market Cap
1.30 Mil1.54 Bil14.70 Mil
Industry
Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Nunzia Pharmaceutical Corp Stock

No. NUNZ does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

NUNZ’s market cap is 1.30 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

NUNZ’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare NUNZ’s historical performance against its industry peers and the overall market.